JP2008532516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008532516A5 JP2008532516A5 JP2008500763A JP2008500763A JP2008532516A5 JP 2008532516 A5 JP2008532516 A5 JP 2008532516A5 JP 2008500763 A JP2008500763 A JP 2008500763A JP 2008500763 A JP2008500763 A JP 2008500763A JP 2008532516 A5 JP2008532516 A5 JP 2008532516A5
- Authority
- JP
- Japan
- Prior art keywords
- increased
- reduced
- cells
- average
- mean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66117305P | 2005-03-11 | 2005-03-11 | |
| US74052205P | 2005-11-29 | 2005-11-29 | |
| PCT/US2006/007353 WO2006098887A2 (en) | 2005-03-11 | 2006-02-27 | Gene disruptions, compositions and methods relating thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009049942A Division JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008532516A JP2008532516A (ja) | 2008-08-21 |
| JP2008532516A5 true JP2008532516A5 (enExample) | 2009-04-23 |
Family
ID=36992194
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008500763A Pending JP2008532516A (ja) | 2005-03-11 | 2006-02-27 | 遺伝子破壊、組成物、およびそれに関連する方法 |
| JP2009049942A Pending JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009049942A Pending JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110097330A1 (enExample) |
| EP (1) | EP1863340A2 (enExample) |
| JP (2) | JP2008532516A (enExample) |
| AU (1) | AU2006223579A1 (enExample) |
| CA (1) | CA2601677A1 (enExample) |
| WO (1) | WO2006098887A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| WO2006012232A1 (en) | 2004-06-24 | 2006-02-02 | Mayo Foundation For Medical Education And Research | B7-h5, a costimulatory polypeptide |
| US8989833B2 (en) | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
| US8231872B2 (en) * | 2005-04-25 | 2012-07-31 | The Trustees Of Dartmouth College | Regulatory T cell mediator proteins and uses thereof |
| NZ568015A (en) | 2005-12-08 | 2012-03-30 | Medarex Inc | Human monoclonal antibodies to O8E |
| EP2082052A2 (en) * | 2006-11-14 | 2009-07-29 | Genentech, Inc. | Knockout mice for pro1105, pro1279 or pro1783 coding genes |
| US8591455B2 (en) | 2008-02-21 | 2013-11-26 | Dexcom, Inc. | Systems and methods for customizing delivery of sensor data |
| PT2453921E (pt) | 2009-07-14 | 2015-09-25 | Novartis Ag | Diferenciação de células estaminais mesenquimais |
| HUE028878T2 (en) | 2009-09-03 | 2017-01-30 | Cancer Res Tech Ltd | CLEC14A inhibitors |
| CN104039357A (zh) * | 2011-06-10 | 2014-09-10 | 哈佛学院校长同事会 | 胰腺β-细胞增殖的调节 |
| JO3412B1 (ar) | 2011-06-17 | 2019-10-20 | Regeneron Pharma | أجسام مضادة ل angptl3 واستخداماتها |
| JP6170047B2 (ja) | 2011-08-31 | 2017-07-26 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | アポトーシス−ターゲティングナノ粒子 |
| JP6356614B2 (ja) | 2012-02-17 | 2018-07-11 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | 薬剤のミトコンドリア輸送のためのナノ粒子 |
| UY35368A (es) | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| MA38369B1 (fr) | 2013-03-08 | 2018-10-31 | Novartis Ag | Peptides et compositions pour le traitement d'une lesion de l'articulation |
| CN111803465B (zh) | 2013-03-15 | 2023-05-09 | 阿根塔创新有限公司 | 可咀嚼配制物 |
| WO2015138992A1 (en) | 2014-03-14 | 2015-09-17 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
| EP3411392B1 (en) * | 2016-02-04 | 2021-12-29 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered angptl8 gene |
| MX2018010401A (es) | 2016-03-03 | 2019-03-06 | Regeneron Pharma | Metodos para el tratamiento de pacientes con hiperlipidemia administrando un inhibidor de pcsk9 en combinacion con un inhibidor de angptl3. |
| US10961305B2 (en) | 2016-12-21 | 2021-03-30 | Mereo Biopharma 3 Limited | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta |
| CN111095261A (zh) | 2017-04-27 | 2020-05-01 | 视网膜病答案有限公司 | 眼底图像自动分析系统和方法 |
| TWI817952B (zh) | 2017-08-25 | 2023-10-11 | 美商戊瑞治療有限公司 | Ｂ７－ｈ４抗體及其使用方法 |
| BR112020016986A2 (pt) | 2018-02-21 | 2021-03-02 | Five Prime Therapeutics, Inc. | formulações de anticorpo contra b7-h4 |
| CA3091801A1 (en) | 2018-03-02 | 2019-09-06 | Five Prime Therapeutics, Inc. | B7-h4 antibodies and methods of use thereof |
| US12089930B2 (en) | 2018-03-05 | 2024-09-17 | Marquette University | Method and apparatus for non-invasive hemoglobin level prediction |
| AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
| EP3965740A1 (en) * | 2019-05-10 | 2022-03-16 | KetoSwiss AG | Ketone bodies enclosed in microbeads |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7339033B2 (en) * | 1998-06-26 | 2008-03-04 | Genentech, Inc. | Pro1481 |
| JP2003518361A (ja) * | 1998-09-01 | 2003-06-10 | ジェネンテック・インコーポレーテッド | 更なるｐｒｏポリペプチドとその配列 |
| KR100553300B1 (ko) * | 1999-03-08 | 2006-02-20 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 방법 |
| KR100543857B1 (ko) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
| AU6802801A (en) * | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU2002217989A1 (en) * | 2000-11-15 | 2002-05-27 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
| WO2002045495A2 (en) * | 2000-12-06 | 2002-06-13 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
-
2006
- 2006-02-27 EP EP06736637A patent/EP1863340A2/en not_active Withdrawn
- 2006-02-27 JP JP2008500763A patent/JP2008532516A/ja active Pending
- 2006-02-27 CA CA002601677A patent/CA2601677A1/en not_active Abandoned
- 2006-02-27 WO PCT/US2006/007353 patent/WO2006098887A2/en not_active Ceased
- 2006-02-27 AU AU2006223579A patent/AU2006223579A1/en not_active Abandoned
- 2006-02-27 US US11/722,967 patent/US20110097330A1/en not_active Abandoned
-
2009
- 2009-03-03 JP JP2009049942A patent/JP2009168820A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lundberg et al. | Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPα-interaction | |
| Kruger et al. | Stereochemical control yields mucin mimetic polymers | |
| ES2655591T3 (es) | Métodos para la regulación de células madre | |
| ES2379413T3 (es) | Procedimientos para detectar la enfermedad inflamatoria del intestino | |
| KR20240116566A (ko) | 노화 세포 치료를 위한 단백질 치료제 | |
| JP2009168820A (ja) | 遺伝子破壊、組成物、およびそれに関連する方法 | |
| Chrobak et al. | CD73 plays a protective role in collagen-induced arthritis | |
| DE60128701T2 (de) | Claudin polypeptide | |
| WO2012061537A9 (en) | Methods for treating hair loss disorders | |
| CA2298540A1 (en) | Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof | |
| JP2003524387A (ja) | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 | |
| US20030143579A1 (en) | Inhibitors of apoptosis | |
| Bonaventura et al. | Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis | |
| JP2002503451A (ja) | カプサイシン受容体をコードする核酸配列 | |
| JP6890835B2 (ja) | 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用 | |
| DE69931284T9 (de) | Menschliches Neurotrimin-Homolog | |
| Singh et al. | Functional roles of osteoactivin in normal and disease processes | |
| US20110020380A1 (en) | Human Tumor Necrosis Factor TR18 and Methods Based Thereon | |
| JP2005511012A (ja) | ヒトｃＤＮＡおよびタンパク質およびその使用 | |
| Yang et al. | Quadruped gait and regulation of apoptotic factors in Tibiofemoral joints following intra-articular rhPRG4 injection in Prg4 null mice | |
| ES2262819T3 (es) | Ligando natural para el receptor gpr86 acoplado a proteinas g huerfano y metodos de uso. | |
| EP1756270A2 (en) | Diagnosis and treatment of myeloid and lymphoid cell cancers | |
| Yang et al. | Structural insight for roles of DR5 death domain mutations on oligomerization of DR5 death domain–FADD complex in the death-inducing signaling complex formation: a computational study | |
| US10485849B2 (en) | Syndecan peptides and polypeptides as inhibitors of vascular endothelial growth factor receptor-2 (VEGFR2) and very late antigen-4 (VLA-4) | |
| WO2023034993A1 (en) | Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases |